Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date B...
-AmerisourceBergen, a global healthcare company, today announced the launch of its Cell and Gene Therapy (CGT) Integration Hub, a system that can be integr...
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today...
These new patents complement the company's strong international portfolio of 20 families and more than 78 patents covering the concept, design, production ...
Indica Labs, an industry leader in quantitative digital pathology and image management innovations, and Lunit, a leading medical AI software platform compa...
Agilent Technologies Inc. (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with Theragen Bio in South Korea to boos...
Cutting-edge technology now available in Mobius® 3D process containers Provides 10 times greater abrasion resistance compared to other single-use bi...
Expanded facility to manufacture mRNA-based therapies and vaccines Researchers at the University of Adelaide will address the design and manufacturi...
Triple quadrupole mass spectrometers (LC/MS/MS) are established in labs dealing with challenging matrices, as they offer very low detection limits with spe...
A balanced microbiome plays an important role in maintaining human health by promoting protective immune responses and limiting excessive inflammation. But...
Several of the tests are Research Use Only (RUO) such as the RUO LENA Q51® introduced by Alercell in January 2023. LENA Q51® is the most comprehens...
Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotid...
Revenue Up 5.8% Year-Over-Year to RMB8,964 MillionNet Profit Attributable to Owners of the Company Up 32.0% Year-Over-Year to RMB2,168 MillionDiluted ...
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that its QIAstat-Dx syndromic testing solution is expected to be available soon for use ...
© 2025 Biopharma Boardroom. All Rights Reserved.
